Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Connie Hess

Concepts (260)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peripheral Arterial Disease
48
2024
458
12.200
 Why?
Percutaneous Coronary Intervention
22
2021
467
4.550
 Why?
Coronary Artery Disease
17
2024
680
4.480
 Why?
Lower Extremity
24
2024
407
4.460
 Why?
Myocardial Infarction
18
2023
1021
3.920
 Why?
Platelet Aggregation Inhibitors
27
2024
443
3.520
 Why?
Fibrinolytic Agents
12
2024
262
3.350
 Why?
Endovascular Procedures
8
2024
301
2.890
 Why?
Radial Artery
9
2019
69
2.650
 Why?
Purinergic P2Y Receptor Antagonists
8
2018
66
2.390
 Why?
Acute Coronary Syndrome
7
2023
267
2.250
 Why?
Rivaroxaban
15
2024
252
2.140
 Why?
Vascular Surgical Procedures
7
2024
295
2.130
 Why?
Aspirin
15
2024
380
2.070
 Why?
Ischemia
9
2023
405
1.750
 Why?
Femoral Artery
9
2024
174
1.730
 Why?
Stroke
10
2022
1072
1.580
 Why?
Treatment Outcome
42
2024
10241
1.470
 Why?
Anticoagulants
10
2024
637
1.450
 Why?
Hemorrhage
16
2024
680
1.430
 Why?
Drug-Eluting Stents
4
2021
74
1.380
 Why?
Postoperative Complications
6
2021
2481
1.330
 Why?
Anticholesteremic Agents
3
2023
150
1.310
 Why?
Hypercholesterolemia
2
2022
102
1.260
 Why?
Atherosclerosis
6
2024
402
1.250
 Why?
Cholesterol, LDL
5
2024
358
1.240
 Why?
Venous Thromboembolism
2
2023
287
1.210
 Why?
Patient Readmission
4
2021
668
1.200
 Why?
Aged
44
2024
22107
1.070
 Why?
Factor Xa Inhibitors
7
2024
170
1.050
 Why?
Atrial Fibrillation
4
2017
376
1.050
 Why?
Cardiovascular Diseases
7
2024
2008
1.050
 Why?
Disease Management
4
2021
592
1.020
 Why?
Humans
99
2024
129847
1.010
 Why?
Ticlopidine
3
2016
54
0.990
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5
2024
430
0.950
 Why?
Saphenous Vein
2
2015
32
0.930
 Why?
Graft Occlusion, Vascular
2
2015
41
0.920
 Why?
Cardiac Catheterization
3
2018
520
0.880
 Why?
Learning Curve
2
2015
69
0.870
 Why?
Middle Aged
40
2024
31177
0.870
 Why?
Female
56
2024
68829
0.860
 Why?
Thrombosis
4
2024
349
0.860
 Why?
Risk Factors
26
2024
9801
0.840
 Why?
Male
50
2024
63759
0.830
 Why?
Coronary Artery Bypass
2
2015
224
0.830
 Why?
Warfarin
2
2015
147
0.820
 Why?
Pyridones
2
2015
158
0.810
 Why?
Fibrin Fibrinogen Degradation Products
1
2023
82
0.810
 Why?
Antifibrinolytic Agents
1
2023
49
0.800
 Why?
Coronary Vessels
4
2024
239
0.790
 Why?
Sex Characteristics
3
2023
735
0.790
 Why?
Postoperative Hemorrhage
2
2013
88
0.770
 Why?
Brain Ischemia
2
2022
321
0.760
 Why?
Paclitaxel
2
2021
218
0.730
 Why?
Blood Coagulation Disorders
1
2023
167
0.730
 Why?
Diabetes Complications
2
2021
224
0.720
 Why?
Gout
2
2018
33
0.720
 Why?
Pyrazoles
2
2015
403
0.710
 Why?
Heparin
3
2023
254
0.710
 Why?
Hypolipidemic Agents
1
2021
92
0.690
 Why?
Registries
12
2024
1903
0.680
 Why?
Angina Pectoris
2
2017
67
0.670
 Why?
Dyslipidemias
1
2021
177
0.630
 Why?
Leg
1
2021
240
0.630
 Why?
Patient Care Team
1
2024
603
0.620
 Why?
Drug Therapy, Combination
11
2024
1042
0.600
 Why?
Myocardial Revascularization
2
2016
72
0.600
 Why?
Reperfusion
1
2018
38
0.600
 Why?
Coronary Angiography
4
2024
306
0.590
 Why?
Risk Assessment
11
2021
3269
0.590
 Why?
Consensus
2
2017
622
0.560
 Why?
Upper Extremity
1
2018
95
0.550
 Why?
Time Factors
13
2021
6550
0.540
 Why?
American Heart Association
5
2024
300
0.530
 Why?
Databases, Factual
2
2021
1269
0.520
 Why?
Societies, Medical
3
2024
759
0.490
 Why?
Medicare
4
2021
719
0.480
 Why?
Quality Indicators, Health Care
3
2023
298
0.470
 Why?
Acute Disease
4
2021
980
0.470
 Why?
Popliteal Artery
4
2024
58
0.450
 Why?
United States
23
2024
13913
0.450
 Why?
Coronary Disease
1
2017
385
0.440
 Why?
Intermittent Claudication
3
2024
118
0.440
 Why?
Coronary Vessel Anomalies
2
2024
33
0.440
 Why?
Recurrence
5
2020
1013
0.440
 Why?
Cardiology
4
2024
266
0.440
 Why?
Follow-Up Studies
6
2021
4896
0.430
 Why?
Hospitals
3
2017
649
0.430
 Why?
Office Visits
1
2013
87
0.410
 Why?
Sex Factors
8
2024
1973
0.410
 Why?
Hematoma
2
2022
53
0.380
 Why?
Aftercare
1
2013
206
0.370
 Why?
Vascular Diseases
2
2024
240
0.360
 Why?
Subclavian Vein
1
2011
15
0.360
 Why?
Subclavian Artery
1
2011
28
0.360
 Why?
Health Status Disparities
1
2014
256
0.360
 Why?
Comorbidity
5
2024
1551
0.350
 Why?
Arteriovenous Fistula
1
2011
35
0.350
 Why?
Thrombocytopenia
1
2012
189
0.350
 Why?
Referral and Consultation
1
2016
735
0.340
 Why?
Electric Countershock
1
2011
105
0.340
 Why?
Quality of Life
3
2022
2695
0.340
 Why?
Catheterization
1
2011
176
0.340
 Why?
Adenosine Diphosphate
1
2009
81
0.320
 Why?
Proportional Hazards Models
4
2021
1199
0.310
 Why?
Nitric Oxide Synthase Type III
1
2009
203
0.300
 Why?
Cardiovascular Agents
2
2022
157
0.300
 Why?
Retrospective Studies
9
2024
14553
0.300
 Why?
Prospective Studies
8
2024
7158
0.300
 Why?
Randomized Controlled Trials as Topic
1
2014
1368
0.290
 Why?
Gene Expression Regulation, Enzymologic
1
2009
284
0.290
 Why?
AMP-Activated Protein Kinases
1
2009
190
0.290
 Why?
Peptides
1
2013
926
0.290
 Why?
Defibrillators, Implantable
1
2011
300
0.280
 Why?
Healthcare Disparities
1
2014
580
0.280
 Why?
Vascular System Injuries
2
2019
73
0.280
 Why?
Catheterization, Peripheral
2
2019
105
0.270
 Why?
Cardiomyopathies
1
2011
340
0.270
 Why?
Cause of Death
3
2018
395
0.260
 Why?
Double-Blind Method
4
2020
1877
0.260
 Why?
Aged, 80 and over
7
2021
7066
0.250
 Why?
Ankle Brachial Index
2
2022
36
0.230
 Why?
Neoplasms
2
2017
2454
0.220
 Why?
Kaplan-Meier Estimate
3
2021
851
0.220
 Why?
Endothelial Cells
1
2009
749
0.220
 Why?
Patient Discharge
3
2021
856
0.210
 Why?
Age Factors
4
2016
3161
0.210
 Why?
Arteries
2
2022
266
0.210
 Why?
Thromboplastin
1
2023
70
0.210
 Why?
Incidence
5
2021
2646
0.200
 Why?
Longitudinal Studies
5
2018
2724
0.200
 Why?
Migraine Disorders
1
2024
101
0.200
 Why?
Myocardial Ischemia
2
2015
259
0.200
 Why?
Numbers Needed To Treat
1
2021
7
0.190
 Why?
Ulcer
1
2021
28
0.190
 Why?
Odds Ratio
2
2022
1022
0.180
 Why?
Lactones
1
2022
55
0.180
 Why?
Walking
2
2022
500
0.180
 Why?
Syndrome
1
2021
338
0.170
 Why?
Clinical Trials as Topic
2
2017
1005
0.170
 Why?
Angioplasty, Balloon
1
2021
92
0.170
 Why?
Cholesterol
1
2022
412
0.170
 Why?
Limb Salvage
1
2020
57
0.170
 Why?
Antineoplastic Agents, Phytogenic
1
2021
187
0.170
 Why?
United Kingdom
1
2020
258
0.160
 Why?
Pharmaceutical Preparations
1
2021
171
0.160
 Why?
Secondary Prevention
1
2020
220
0.160
 Why?
Patient Education as Topic
1
2024
743
0.160
 Why?
Hospitalization
2
2019
2079
0.160
 Why?
Extremities
1
2020
127
0.150
 Why?
Aorta
1
2021
408
0.150
 Why?
Receptors, Purinergic P2Y12
1
2018
6
0.150
 Why?
Hypertension
2
2022
1242
0.150
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2018
24
0.150
 Why?
Pyridines
1
2022
478
0.150
 Why?
Cohort Studies
2
2022
5444
0.140
 Why?
Antithrombins
1
2018
58
0.140
 Why?
Exercise Therapy
1
2022
413
0.140
 Why?
Non-ST Elevated Myocardial Infarction
1
2017
19
0.140
 Why?
Stents
3
2020
504
0.140
 Why?
Practice Guidelines as Topic
2
2017
1514
0.140
 Why?
Plaque, Atherosclerotic
1
2017
55
0.130
 Why?
ST Elevation Myocardial Infarction
1
2017
52
0.130
 Why?
Intraoperative Complications
1
2017
129
0.130
 Why?
Diabetes Mellitus, Type 2
2
2024
2444
0.130
 Why?
Mortality
1
2018
308
0.130
 Why?
Stress Disorders, Post-Traumatic
1
2024
813
0.130
 Why?
Uric Acid
1
2017
161
0.120
 Why?
Antibodies, Monoclonal
2
2023
1368
0.120
 Why?
North Carolina
1
2015
99
0.120
 Why?
Blood Platelets
1
2018
386
0.120
 Why?
Hospital Bed Capacity
1
2014
25
0.120
 Why?
Hospitals, Low-Volume
1
2014
22
0.120
 Why?
Hospitals, High-Volume
1
2014
39
0.110
 Why?
Smoking
1
2022
1502
0.110
 Why?
Clinical Trials Data Monitoring Committees
1
2014
6
0.110
 Why?
Vascular Patency
1
2014
102
0.110
 Why?
Prosthesis Design
2
2017
309
0.110
 Why?
Diagnosis-Related Groups
1
2013
29
0.110
 Why?
Diabetes Mellitus
1
2022
1003
0.110
 Why?
Professional Competence
1
2014
96
0.100
 Why?
Survivors
1
2017
464
0.100
 Why?
Logistic Models
1
2018
1989
0.100
 Why?
Guideline Adherence
1
2017
527
0.100
 Why?
Fee-for-Service Plans
1
2013
88
0.100
 Why?
Practice Patterns, Physicians'
2
2018
1274
0.100
 Why?
Platelet Factor 4
1
2012
34
0.100
 Why?
Infusions, Intravenous
1
2013
402
0.100
 Why?
Antibodies, Monoclonal, Humanized
1
2017
756
0.100
 Why?
Inflammation
1
2023
2748
0.100
 Why?
Heart Failure
2
2016
2148
0.090
 Why?
Prognosis
2
2021
3773
0.090
 Why?
Prevalence
3
2024
2564
0.080
 Why?
Radiography, Interventional
1
2011
105
0.080
 Why?
Reoperation
2
2024
542
0.080
 Why?
Naphthalimides
1
2009
2
0.080
 Why?
Calcium-Calmodulin-Dependent Protein Kinase Kinase
1
2009
4
0.080
 Why?
Heart Diseases
1
2013
352
0.080
 Why?
Hospital Mortality
1
2014
852
0.080
 Why?
Predictive Value of Tests
1
2014
1951
0.080
 Why?
Sensitivity and Specificity
1
2013
1847
0.080
 Why?
Benzimidazoles
1
2009
162
0.070
 Why?
Communication
1
2014
847
0.070
 Why?
Protein Isoforms
1
2009
393
0.070
 Why?
Case-Control Studies
1
2015
3384
0.070
 Why?
Enzyme Activation
1
2009
813
0.070
 Why?
Combined Modality Therapy
2
2021
1201
0.070
 Why?
Phosphatidylinositol 3-Kinases
1
2009
362
0.070
 Why?
Clinical Competence
1
2014
1020
0.070
 Why?
Cattle
1
2009
978
0.070
 Why?
Quality Improvement
1
2014
1112
0.060
 Why?
Phosphorylation
1
2009
1716
0.060
 Why?
Cell Movement
1
2009
950
0.060
 Why?
Young Adult
1
2021
12467
0.060
 Why?
Autoantibodies
1
2012
1468
0.060
 Why?
Fibromuscular Dysplasia
1
2024
7
0.060
 Why?
Atherectomy
1
2024
37
0.060
 Why?
Subtilisin
1
2023
3
0.050
 Why?
Proprotein Convertases
1
2023
15
0.050
 Why?
Angiography
1
2024
197
0.050
 Why?
Proprotein Convertase 9
1
2023
68
0.050
 Why?
Lipoprotein(a)
1
2023
67
0.050
 Why?
Adult
2
2024
35634
0.050
 Why?
Disability Evaluation
1
2024
285
0.050
 Why?
Adolescent
1
2021
20451
0.050
 Why?
Mobility Limitation
1
2022
61
0.050
 Why?
Public Health Surveillance
1
2021
68
0.040
 Why?
Coated Materials, Biocompatible
1
2021
59
0.040
 Why?
Diagnostic Tests, Routine
1
2021
104
0.040
 Why?
Smoking Cessation
1
2024
409
0.040
 Why?
Internationality
1
2020
150
0.040
 Why?
Disease Susceptibility
1
2021
334
0.040
 Why?
Advisory Committees
1
2021
216
0.040
 Why?
Punctures
1
2019
40
0.040
 Why?
Global Health
1
2021
329
0.040
 Why?
Health Care Costs
1
2021
367
0.040
 Why?
Drug Utilization Review
1
2017
57
0.030
 Why?
Socioeconomic Factors
1
2021
1214
0.030
 Why?
Surgery, Computer-Assisted
1
2017
77
0.030
 Why?
Dose-Response Relationship, Drug
1
2021
2016
0.030
 Why?
Comparative Effectiveness Research
1
2017
151
0.030
 Why?
Chi-Square Distribution
1
2017
515
0.030
 Why?
Signal Transduction
1
2009
4935
0.030
 Why?
Genetic Predisposition to Disease
1
2024
2271
0.030
 Why?
Drug Prescriptions
1
2017
249
0.030
 Why?
Platelet Function Tests
1
2015
25
0.030
 Why?
Patient Selection
1
2019
660
0.030
 Why?
Hypoglycemic Agents
1
2024
1221
0.030
 Why?
Depression
1
2024
1323
0.030
 Why?
Administration, Oral
1
2017
787
0.030
 Why?
Early Termination of Clinical Trials
1
2014
15
0.030
 Why?
Multivariate Analysis
1
2017
1501
0.030
 Why?
Mass Screening
1
2021
1192
0.030
 Why?
Retreatment
1
2013
70
0.030
 Why?
Canada
1
2014
353
0.030
 Why?
Patient Preference
1
2014
184
0.020
 Why?
Linear Models
1
2014
822
0.020
 Why?
Pregnancy
1
2023
6423
0.020
 Why?
Animals
1
2009
35409
0.020
 Why?
Hess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (260) concept(s)
_
Co-Authors Expand Description
See all (19) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)